Will patient-centric sampling become the norm for clinical trials after COVID-19?

Nat Med. 2020 Dec;26(12):1810. doi: 10.1038/s41591-020-01144-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • COVID-19* / pathology
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards*
  • Diagnostic Techniques and Procedures / standards
  • Diagnostic Techniques and Procedures / trends*
  • Humans
  • Molecular Diagnostic Techniques / methods
  • Molecular Diagnostic Techniques / standards
  • Molecular Diagnostic Techniques / trends
  • Pandemics
  • Patient-Centered Care / methods*
  • Patient-Centered Care / standards
  • Patient-Centered Care / trends
  • Reference Standards
  • Research Design
  • SARS-CoV-2
  • Specimen Handling* / methods
  • Specimen Handling* / standards
  • Specimen Handling* / trends
  • Telemedicine / methods
  • Telemedicine / standards
  • Telemedicine / trends
  • United States / epidemiology